These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12409256)

  • 1. Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL.
    Kim SH; Kim S; Oligino TJ; Robbins PD
    Mol Ther; 2002 Nov; 6(5):584-90. PubMed ID: 12409256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.
    Kim SH; Bianco N; Menon R; Lechman ER; Shufesky WJ; Morelli AE; Robbins PD
    Mol Ther; 2006 Feb; 13(2):289-300. PubMed ID: 16275099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
    Zhang H; Yang Y; Horton JL; Samoilova EB; Judge TA; Turka LA; Wilson JM; Chen Y
    J Clin Invest; 1997 Oct; 100(8):1951-7. PubMed ID: 9329958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gamma delta T cells in murine collagen-induced arthritis.
    Peterman GM; Spencer C; Sperling AI; Bluestone JA
    J Immunol; 1993 Dec; 151(11):6546-58. PubMed ID: 8245484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
    Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
    Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
    Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
    Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
    Chen J; Zhang XM; Xu Q
    Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis.
    Guéry L; Batteux F; Bessis N; Breban M; Boissier MC; Fournier C; Chiocchia G
    Eur J Immunol; 2000 Jan; 30(1):308-15. PubMed ID: 10602054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
    Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
    J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-γ and nitric oxide.
    Xu X; Yi H; Guo Z; Qian C; Xia S; Yao Y; Cao X
    J Immunol; 2012 Feb; 188(3):1168-77. PubMed ID: 22205032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells.
    Chen A; Xu H; Choi Y; Wang B; Zheng G
    Cell Immunol; 2004; 231(1-2):40-8. PubMed ID: 15919368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts.
    Ohata J; Miura T; Johnson TA; Hori S; Ziegler SF; Kohsaka H
    Arthritis Rheum; 2007 Sep; 56(9):2947-56. PubMed ID: 17763426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
    Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
    Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S; Krause SW; Herfarth H; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities.
    Hom JT; Butler LD; Riedl PE; Bendele AM
    Eur J Immunol; 1988 Jun; 18(6):881-8. PubMed ID: 3260183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance.
    Derry CJ; Harper N; Davies DH; Murphy JJ; Staines NA
    Arthritis Rheum; 2001 Aug; 44(8):1917-27. PubMed ID: 11508445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.